EFNB1 and neurodegenerative disease: Based on the results of our knockdown experiments, targeting microglial ephrin-B1, and plausibly other microglial ephrin-B molecules, may provide a more viable option to minimize the deleterious neuroinflammation seen in the CNS in viral encephalitis stemming from HIV or potentially other neurodegenerative diseases.